FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366463387> ?p ?o ?g. }

• W4366463387 endingPage "1159" @default.
• W4366463387 startingPage "1153" @default.
• W4366463387 abstract "Objective The aim of the study is to compare the efficacy and safety of 3 chemotherapy regimens used as first-line treatments in the real-life management of metastatic pancreatic cancer. Methods A total of 218 patients were included in this multicenter study. Gemcitabine (Gem, n = 71), gemcitabine-cisplatin (Gem-Cis, n = 91), and FOLFIRINOX (a combination of leucovorin, 5-fluorouracil, irinotecan, and oxaliplatin [FFX], n = 56) treatments were compared. Results Overall response rate was significantly higher in the FFX group (50.0%) than in the Gem (28.2%) and Gem-Cis (27.5%) groups (P = 0.010). Median progression-free survival (8.4 vs 4.6 and 5.5 months, respectively, P < 0.001) and overall survival (16.4 vs 8.1 and 8.7 months, respectively, P = 0.002) were significantly longer in the FFX group than in the Gem and Gem-Cis groups. Toxicity of any grade was noted in 46 (64.8%), 56 (61.5%), and 49 (87.5%) patients in the Gem, Gem-Cis, and FFX groups, respectively (P = 0.003). Conclusions In our study, FFX regimen provides a significant advantage over the other treatment regimens in terms of response rates and survival. Treatment toxicity was more frequent but manageable with the FFX regimen." @default.
• W4366463387 created "2023-04-22" @default.
• W4366463387 creator A5000554665 @default.
• W4366463387 creator A5011664783 @default.
• W4366463387 creator A5022118788 @default.
• W4366463387 creator A5029649611 @default.
• W4366463387 creator A5033323622 @default.
• W4366463387 creator A5033820961 @default.
• W4366463387 creator A5041705584 @default.
• W4366463387 creator A5050192409 @default.
• W4366463387 creator A5052112651 @default.
• W4366463387 creator A5053729961 @default.
• W4366463387 creator A5068468956 @default.
• W4366463387 creator A5071752002 @default.
• W4366463387 creator A5075464633 @default.
• W4366463387 creator A5085709455 @default.
• W4366463387 date "2022-10-01" @default.
• W4366463387 modified "2023-09-30" @default.
• W4366463387 title "The Efficacy and Safety of Treatment Regimens Used in the First-Line Setting in Metastatic Pancreatic Cancer Patients" @default.
• W4366463387 cites W1931508686 @default.
• W4366463387 cites W1996912024 @default.
• W4366463387 cites W2011924434 @default.
• W4366463387 cites W2101465269 @default.
• W4366463387 cites W2151253787 @default.
• W4366463387 cites W2158397794 @default.
• W4366463387 cites W2165480504 @default.
• W4366463387 cites W2226183012 @default.
• W4366463387 cites W2317504614 @default.
• W4366463387 cites W2415398754 @default.
• W4366463387 cites W2480793872 @default.
• W4366463387 cites W2781525129 @default.
• W4366463387 cites W2801295380 @default.
• W4366463387 cites W4211208840 @default.
• W4366463387 cites W4297819854 @default.
• W4366463387 cites W801273722 @default.
• W4366463387 doi "https://doi.org/10.1097/mpa.0000000000002167" @default.
• W4366463387 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37078939" @default.
• W4366463387 hasPublicationYear "2022" @default.
• W4366463387 type Work @default.
• W4366463387 citedByCount "0" @default.
• W4366463387 crossrefType "journal-article" @default.
• W4366463387 hasAuthorship W4366463387A5000554665 @default.
• W4366463387 hasAuthorship W4366463387A5011664783 @default.
• W4366463387 hasAuthorship W4366463387A5022118788 @default.
• W4366463387 hasAuthorship W4366463387A5029649611 @default.
• W4366463387 hasAuthorship W4366463387A5033323622 @default.
• W4366463387 hasAuthorship W4366463387A5033820961 @default.
• W4366463387 hasAuthorship W4366463387A5041705584 @default.
• W4366463387 hasAuthorship W4366463387A5050192409 @default.
• W4366463387 hasAuthorship W4366463387A5052112651 @default.
• W4366463387 hasAuthorship W4366463387A5053729961 @default.
• W4366463387 hasAuthorship W4366463387A5068468956 @default.
• W4366463387 hasAuthorship W4366463387A5071752002 @default.
• W4366463387 hasAuthorship W4366463387A5075464633 @default.
• W4366463387 hasAuthorship W4366463387A5085709455 @default.
• W4366463387 hasConcept C121608353 @default.
• W4366463387 hasConcept C126322002 @default.
• W4366463387 hasConcept C141071460 @default.
• W4366463387 hasConcept C143998085 @default.
• W4366463387 hasConcept C2776694085 @default.
• W4366463387 hasConcept C2777148230 @default.
• W4366463387 hasConcept C2780210213 @default.
• W4366463387 hasConcept C2780258809 @default.
• W4366463387 hasConcept C2780259306 @default.
• W4366463387 hasConcept C2780456651 @default.
• W4366463387 hasConcept C2780962732 @default.
• W4366463387 hasConcept C2781413609 @default.
• W4366463387 hasConcept C29730261 @default.
• W4366463387 hasConcept C526805850 @default.
• W4366463387 hasConcept C71924100 @default.
• W4366463387 hasConcept C90924648 @default.
• W4366463387 hasConceptScore W4366463387C121608353 @default.
• W4366463387 hasConceptScore W4366463387C126322002 @default.
• W4366463387 hasConceptScore W4366463387C141071460 @default.
• W4366463387 hasConceptScore W4366463387C143998085 @default.
• W4366463387 hasConceptScore W4366463387C2776694085 @default.
• W4366463387 hasConceptScore W4366463387C2777148230 @default.
• W4366463387 hasConceptScore W4366463387C2780210213 @default.
• W4366463387 hasConceptScore W4366463387C2780258809 @default.
• W4366463387 hasConceptScore W4366463387C2780259306 @default.
• W4366463387 hasConceptScore W4366463387C2780456651 @default.
• W4366463387 hasConceptScore W4366463387C2780962732 @default.
• W4366463387 hasConceptScore W4366463387C2781413609 @default.
• W4366463387 hasConceptScore W4366463387C29730261 @default.
• W4366463387 hasConceptScore W4366463387C526805850 @default.
• W4366463387 hasConceptScore W4366463387C71924100 @default.
• W4366463387 hasConceptScore W4366463387C90924648 @default.
• W4366463387 hasIssue "9" @default.
• W4366463387 hasLocation W43664633871 @default.
• W4366463387 hasLocation W43664633872 @default.
• W4366463387 hasOpenAccess W4366463387 @default.
• W4366463387 hasPrimaryLocation W43664633871 @default.
• W4366463387 hasRelatedWork W1883975635 @default.
• W4366463387 hasRelatedWork W1974538215 @default.
• W4366463387 hasRelatedWork W2206740068 @default.
• W4366463387 hasRelatedWork W2476389627 @default.
• W4366463387 hasRelatedWork W2599910524 @default.
• W4366463387 hasRelatedWork W2910998150 @default.

• next